Molina Healthcare Future Growth
Future criteria checks 4/6
Molina Healthcare is forecast to grow earnings and revenue by 14.7% and 10.6% per annum respectively. EPS is expected to grow by 14.6% per annum. Return on equity is forecast to be 22.7% in 3 years.
Key information
14.7%
Earnings growth rate
14.6%
EPS growth rate
| Healthcare earnings growth | 15.7% |
| Revenue growth rate | 10.6% |
| Future return on equity | 22.7% |
| Analyst coverage | Good |
| Last updated | 15 Apr 2024 |
Recent future growth updates
Recent updates
Molina Healthcare (NYSE:MOH) Seems To Use Debt Rather Sparingly
Apr 15
Molina Healthcare, Inc.'s (NYSE:MOH) Popularity With Investors Is Clear
Apr 01Should You Be Adding Molina Healthcare (NYSE:MOH) To Your Watchlist Today?
Mar 18An Intrinsic Calculation For Molina Healthcare, Inc. (NYSE:MOH) Suggests It's 35% Undervalued
Mar 04Molina Healthcare: Attractive Risk-Reward Calculus Over All Horizons
Jan 26Molina Healthcare (NYSE:MOH) Will Be Hoping To Turn Its Returns On Capital Around
Jan 16Does Molina Healthcare (NYSE:MOH) Have A Healthy Balance Sheet?
Jan 02Investors Still Waiting For A Pull Back In Molina Healthcare, Inc. (NYSE:MOH)
Dec 20Here's Why We Think Molina Healthcare (NYSE:MOH) Might Deserve Your Attention Today
Dec 06An Intrinsic Calculation For Molina Healthcare, Inc. (NYSE:MOH) Suggests It's 46% Undervalued
Nov 08Molina Healthcare Q3: Robust Growth Potential Yet Underrated Compared To Peers
Oct 30Shareholders Are Optimistic That Molina Healthcare (NYSE:MOH) Will Multiply In Value
Oct 11Molina Healthcare: Stable State Governments Contracts, And Undervalued
Sep 11We Think Molina Healthcare (NYSE:MOH) Can Manage Its Debt With Ease
Sep 08Here's Why Molina Healthcare (NYSE:MOH) Has Caught The Eye Of Investors
Aug 21Molina Healthcare: A Hidden Compounder In Managed Healthcare
Jul 17Investors Shouldn't Overlook Molina Healthcare's (NYSE:MOH) Impressive Returns On Capital
Jul 09Is There An Opportunity With Molina Healthcare, Inc.'s (NYSE:MOH) 43% Undervaluation?
May 29Here's Why We Think Molina Healthcare (NYSE:MOH) Is Well Worth Watching
May 15Molina Healthcare (NYSE:MOH) Has A Rock Solid Balance Sheet
May 01We Think Molina Healthcare (NYSE:MOH) Might Have The DNA Of A Multi-Bagger
Mar 31Molina Healthcare Is Still Appealing In The Face Of Medicaid Redetermination
Feb 21Is Now The Time To Put Molina Healthcare (NYSE:MOH) On Your Watchlist?
Feb 13Molina Healthcare Non-GAAP EPS of $4.10 beats by $0.08, revenue of $8.22B beats by $350M
Feb 08Molina Healthcare (NYSE:MOH) Could Easily Take On More Debt
Jan 29Molina Healthcare takes $200M impairment on its leased space
Dec 29Molina Healthcare (NYSE:MOH) Could Become A Multi-Bagger
Nov 23Molina Healthcare (NYSE:MOH) Has A Rock Solid Balance Sheet
Oct 25Molina Healthcare: Sacrificing Dividend For Growth Can Pay Off
Oct 20Molina initiated at overweight at JP Morgan on recent Medicaid contracts
Oct 04When Should You Buy Molina Healthcare, Inc. (NYSE:MOH)?
Sep 26Molina Healthcare of New Mexico partners with Pyx Health
Sep 13Molina Healthcare reaches 52-week high; up 29% over last year
Aug 26A Look At The Fair Value Of Molina Healthcare, Inc. (NYSE:MOH)
Aug 17Why The 22% Return On Capital At Molina Healthcare (NYSE:MOH) Should Have Your Attention
Aug 04Molina Healthcare: Stock Expected To Perform Well Despite Recession Risks
Jul 25These 4 Measures Indicate That Molina Healthcare (NYSE:MOH) Is Using Debt Safely
Jul 20Molina Healthcare to acquire My Choice Wisconsin
Jul 13Is Molina Healthcare, Inc. (NYSE:MOH) Potentially Undervalued?
Jun 21Estimating The Fair Value Of Molina Healthcare, Inc. (NYSE:MOH)
May 10Returns on Capital Paint A Bright Future For Molina Healthcare (NYSE:MOH)
Apr 25Does Molina Healthcare (NYSE:MOH) Have A Healthy Balance Sheet?
Apr 09Calculating The Fair Value Of Molina Healthcare, Inc. (NYSE:MOH)
Feb 08The Return Trends At Molina Healthcare (NYSE:MOH) Look Promising
Jan 24These 4 Measures Indicate That Molina Healthcare (NYSE:MOH) Is Using Debt Reasonably Well
Jan 09A Look At The Intrinsic Value Of Molina Healthcare, Inc. (NYSE:MOH)
Nov 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 45,744 | 1,727 | N/A | 2,311 | 7 |
| 12/31/2025 | 42,610 | 1,486 | 1,638 | 2,014 | 12 |
| 12/31/2024 | 39,492 | 1,295 | 1,815 | 1,919 | 12 |
| 12/31/2023 | 33,003 | 1,091 | 1,578 | 1,662 | N/A |
| 9/30/2023 | 32,503 | 931 | 2,041 | 2,140 | N/A |
| 6/30/2023 | 31,835 | 916 | 1,341 | 1,445 | N/A |
| 3/31/2023 | 31,516 | 855 | 1,226 | 1,326 | N/A |
| 12/31/2022 | 31,101 | 792 | 682 | 773 | N/A |
| 9/30/2022 | 30,303 | 839 | 1,480 | 1,582 | N/A |
| 6/30/2022 | 29,435 | 752 | 1,691 | 1,789 | N/A |
| 3/31/2022 | 28,211 | 689 | 1,830 | 1,914 | N/A |
| 12/31/2021 | 26,984 | 659 | 2,042 | 2,119 | N/A |
| 9/30/2021 | 24,656 | 590 | 2,755 | 2,821 | N/A |
| 6/30/2021 | 22,602 | 632 | 2,144 | 2,202 | N/A |
| 3/31/2021 | 20,377 | 723 | 2,254 | 2,323 | N/A |
| 12/31/2020 | 18,375 | 673 | 1,824 | 1,898 | N/A |
| 9/30/2020 | 17,657 | 807 | 537 | 628 | N/A |
| 6/30/2020 | 16,999 | 797 | 946 | 1,028 | N/A |
| 3/31/2020 | 16,692 | 717 | 249 | 321 | N/A |
| 12/31/2019 | 16,340 | 737 | 377 | 434 | N/A |
| 9/30/2019 | 16,674 | 770 | 239 | 275 | N/A |
| 6/30/2019 | 17,054 | 792 | -508 | -472 | N/A |
| 3/31/2019 | 17,644 | 798 | -491 | -459 | N/A |
| 12/31/2018 | 18,144 | 707 | -344 | -314 | N/A |
| 9/30/2018 | 18,500 | 244 | -369 | -344 | N/A |
| 6/30/2018 | 18,921 | -50 | 406 | 446 | N/A |
| 3/31/2018 | 19,133 | -482 | 415 | 479 | N/A |
| 12/31/2017 | 19,445 | -512 | 718 | 804 | N/A |
| 9/30/2017 | 18,722 | -297 | N/A | 997 | N/A |
| 6/30/2017 | 18,216 | -158 | N/A | 1,067 | N/A |
| 3/31/2017 | 17,581 | 105 | N/A | 1,253 | N/A |
| 12/31/2016 | 17,022 | 52 | N/A | 673 | N/A |
| 9/30/2016 | 16,666 | 129 | N/A | 852 | N/A |
| 6/30/2016 | 15,759 | 133 | N/A | 755 | N/A |
| 3/31/2016 | 14,939 | 139 | N/A | 710 | N/A |
| 12/31/2015 | 13,537 | 143 | N/A | 1,125 | N/A |
| 9/30/2015 | 12,728 | 146 | N/A | 1,125 | N/A |
| 6/30/2015 | 11,620 | 116 | N/A | 1,473 | N/A |
| 3/31/2015 | 10,431 | 85 | N/A | 1,403 | N/A |
| 12/31/2014 | 9,373 | 62 | N/A | 1,060 | N/A |
| 9/30/2014 | 8,324 | 20 | N/A | 920 | N/A |
| 6/30/2014 | 7,564 | 11 | N/A | 537 | N/A |
| 3/31/2014 | 6,881 | 19 | N/A | 381 | N/A |
| 12/31/2013 | 6,417 | 45 | N/A | 190 | N/A |
| 9/30/2013 | 6,296 | 80 | N/A | 196 | N/A |
| 6/30/2013 | 6,155 | 72 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MOH's forecast earnings growth (14.7% per year) is above the savings rate (2.3%).
Earnings vs Market: MOH's earnings (14.7% per year) are forecast to grow faster than the US market (14.6% per year).
High Growth Earnings: MOH's earnings are forecast to grow, but not significantly.
Revenue vs Market: MOH's revenue (10.6% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: MOH's revenue (10.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MOH's Return on Equity is forecast to be high in 3 years time (22.7%)